Cardiovascular risk and prevention are central themes in public health initiatives and individual healthcare strategies, given the significant impact of cardiovascular diseases on global morbidity and mortality. Cardiovascular risk factors encompass a range of conditions and behaviors that increase the likelihood of developing heart-related problems. Common risk factors include hypertension, hyperlipidemia, diabetes, smoking, sedentary lifestyle, and poor dietary habits. Identifying and managing these risk factors are critical steps in preventing cardiovascular diseases. Healthcare professionals employ risk assessment tools to estimate an individual's likelihood of experiencing a cardiovascular event over a specified period. Prevention strategies involve lifestyle modifications, including adopting a heart-healthy diet, engaging in regular physical activity, smoking cessation, and managing underlying health conditions. Additionally, pharmacological interventions such as statins or antihypertensive medications may be prescribed when necessary to control specific risk factors.
Title : New mechanisms and innovative therapeutics for pulmonary hypertension
Yong Xiao Wang, Albany Medical Center, United States
Title : STEMI versus acute occlusive myocardial infarction: Which term should we use?
Yochai Birnbaum, Baylor College of Medicine, United States
Title : Preservation of Skeletal Muscle Mass During GLP 1 Receptor Agonist Mediated Weight Loss Clinical Determinants Risk Stratification and Evidence Based Mitigation Strategies
Narendra Kumar, HeartbeatsZ Academy, United Kingdom
Title : A Unique Case of Infective Endocarditis: Staphylococcus lugdunensis Infective Endocarditis Presenting as Embolic Occipital Stroke Due to Posterior Mitral Leaflet Perforation
Nuha Hasnain, Royal Preston Hospital, United Kingdom
Title : New recommendations for the prevention of sudden cardiac death in athletes and recreational sports
Sekib Sokolovic, ASA Hospital Sarajevo, Bosnia and Herzegowina
Title : Coronary revascularization in patients with diabetes: Prospects for stenting in patients with type 1 diabetes and coronary artery disease
Mekhman N Mamedov, National Research Center for Therapy and Preventive Medicine, Russian Federation